These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25569376)

  • 1. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional.
    Sun W; Wang Y; East JE; Kimball AS; Tkaczuk K; Kesmodel S; Strome SE; Webb TJ
    Cytokine; 2015 Mar; 72(1):48-57. PubMed ID: 25569376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
    East JE; Sun W; Webb TJ
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.
    Zeng J; Wang S
    Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.
    Speak AO; Platt N; Salio M; te Vruchte D; Smith DA; Shepherd D; Veerapen N; Besra GS; Yanjanin NM; Simmons L; Imrie J; Wraith JE; Lachmann RH; Hartung R; Runz H; Mengel E; Beck M; Hendriksz CJ; Porter FD; Cerundolo V; Platt FM
    Eur J Immunol; 2012 Jul; 42(7):1886-92. PubMed ID: 22585405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
    Webb TJ; Bieler JG; Schneck JP; Oelke M
    J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis.
    Veenbergen S; Bennink MB; Affandi AJ; Bessis N; Biton J; Arntz OJ; van den Berg WB; van de Loo FA
    Ann Rheum Dis; 2011 Dec; 70(12):2167-75. PubMed ID: 21873688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Invariant Natural Killer T cells possess immune-modulating functions during Aspergillus infection.
    Beitzen-Heineke A; Bouzani M; Schmitt AL; Kurzai O; Hünniger K; Einsele H; Loeffler J
    Med Mycol; 2016 Feb; 54(2):169-76. PubMed ID: 26483428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
    Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
    J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
    Shaulov A; Yue S; Wang R; Joyce RM; Balk SP; Kim HT; Avigan DE; Uhl L; Sackstein R; Exley MA
    Exp Hematol; 2008 Apr; 36(4):464-72. PubMed ID: 18261838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
    Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
    J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo.
    Renukaradhya GJ; Sriram V; Du W; Gervay-Hague J; Van Kaer L; Brutkiewicz RR
    Int J Cancer; 2006 Jun; 118(12):3045-53. PubMed ID: 16395717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.
    Lynch L; O'Shea D; Winter DC; Geoghegan J; Doherty DG; O'Farrelly C
    Eur J Immunol; 2009 Jul; 39(7):1893-901. PubMed ID: 19585513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d and invariant NKT cells at the human maternal-fetal interface.
    Boyson JE; Rybalov B; Koopman LA; Exley M; Balk SP; Racke FK; Schatz F; Masch R; Wilson SB; Strominger JL
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13741-6. PubMed ID: 12368486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
    Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
    Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
    Li L; Yang J; Jiang Y; Tu J; Schust DJ
    Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.
    Shen L; Zhang H; Caimol M; Benike CJ; Chakravarty EF; Strober S; Engleman EG
    Eur J Immunol; 2015 Feb; 45(2):612-23. PubMed ID: 25352488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells.
    Bedard M; Shrestha D; Priestman DA; Wang Y; Schneider F; Matute JD; Iyer SS; Gileadi U; Prota G; Kandasamy M; Veerapen N; Besra G; Fritzsche M; Zeissig S; Shevchenko A; Christianson JC; Platt FM; Eggeling C; Blumberg RS; Salio M; Cerundolo V
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23671-23681. PubMed ID: 31690657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of invariant natural killer T cells in porcine peripheral blood.
    Thierry A; Robin A; Giraud S; Minouflet S; Barra A; Bridoux F; Hauet T; Touchard G; Herbelin A; Gombert JM
    Vet Immunol Immunopathol; 2012 Oct; 149(3-4):272-9. PubMed ID: 22939274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.